China
Africa
Explore chapters and articles related to this topic
Paper 4
Published in Aalia Khan, Ramsey Jabbour, Almas Rehman, nMRCGP Applied Knowledge Test Study Guide, 2021
Aalia Khan, Ramsey Jabbour, Almas Rehman
Chlamydia is most common in sexually active people under the age of 25 years (prevalence of 5–10% of men and women in this age group). Using barrier contraception regularly is a protective factor. A new partner or more than one sexual partner in the last year increases the risk. http://www.bashh.org/guidelines/
The Role of the Practice Nurse in Substance Misuse Treatments
Published in Rosie Winyard, Andrew McBride, Substance Misuse in Primary Care, 2018
A variety of health and social factors may contribute to the increased risk of women developing cervical cancer and are shown in the list. Nurses gaining a history from their clients are in an ideal position to identify these risk factors.10,11Women in a low socio-economic class, particularly IV and V.Early first intercourse.Multiple sexual partners and partners who have had multiple sexual partners.Non-use of barrier contraception.Early first pregnancy, which increases with subsequent pregnancies.Smoking.Human papilloma virus (DNA types 16 and 18).
Life Care Planning for Spinal Cord Injury
Published in Roger O. Weed, Debra E. Berens, Life Care Planning and Case Management Handbook, 2018
David J. Altman, Dan M. Bagwell
Females with spinal cord injury frequently experience disorders of genital sensation, arousal, and orgasm in addition to menstrual irregularities and even cessation of menstruation. Other comorbid conditions that impact sexual health include the presence of decubitus ulcers and bowel and bladder incontinence. The use of oral contraception for females with impaired mobility is relatively contraindicated secondary to the increased risk for deep venous thrombosis. Therefore, barrier contraception is generally recommended.
Management of pulmonary arterial hypertension during pregnancy
Published in Expert Review of Respiratory Medicine, 2023
Kaushiga Krishnathasan, Andrew Constantine, Isma Rafiq, Ana Barradas Pires, Hannah Douglas, Laura C Price, Konstantinos Dimopoulos
Several contraceptive options are available, and collaborative decision-making should be based on patient preference and clinical efficacy and safety profiles. Oral contraceptives include the combined pill and the progesterone-only pill. The latter is preferred due to the greater risk of venous and arterial thromboembolism associated with estrogen in the combined oral contraceptive pill. Progesterone is also available as a subcutaneous implant, inserted under local anesthesia [1,7,48]. Intrauterine devices such as copper and levonorgestrel-coated coils are available. Insertion of such devices is associated with a small risk of a vasovagal response, which can be pronounced in patients with PAH and therefore insertion is usually arranged in a hospital setting [3]. Barrier contraception, such as condoms and diaphragms, can protect from sexually transmitted disease but are not considered reliable forms of contraception in PAH due to contraceptive failure rates and the risk of unplanned pregnancy [1,7].
Investigating College Women’s Contraceptive Choices and Sexuality
Published in International Journal of Sexual Health, 2021
Vimbayi S. Chinopfukutwa, Elizabeth H. Blodgett Salafia
The results of the current study suggest that providing women with contraception that meets their needs and preferences is essential (Marshall et al., 2018). Most college women in our study preferred dual-method contraception. These results are consistent with prior research highlighting that the prevalence of dual-method contraception among emerging adult women has increased (e.g., Raidoo et al., 2020). Motivating factors cited in previous studies for dual-method contraception include the need to improve effectiveness of pregnancy and STI prevention (often apparent at the beginning of a relationship), in situations in which they did not trust their partners or in non-monogamous relationships (Harvey et al., 2018; Lemoine et al., 2017). High level of educational attainment also plays a role in college women’s decision-making process when selecting the dual-method contraception (Raidoo et al., 2020). It is possible that the college women in our study were aware that it is necessary to use birth control pills or any non-barrier contraception with condoms to prevent STI risks as well as the importance of STI testing. Hence, continuous sexual education promoting safe sexual practices is needed. Specifically, providing education that reinforces the importance of preventing STI transmission by encouraging communication between sexual partners about dual- method contraception.
Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid
Published in Journal of Dermatological Treatment, 2019
Sarah Madeline Brown, Khadija Aljefri, Rachel Waas, Philip Hampton
A report from the US National Transplant Pregnancy Registry discusses the outcomes of 74 pregnancies fathered by patients on mycophenolate. Two of these infants were born with birth defects, one with undescended testis and the other with polydactyly. These malformations were not thought to be significantly higher than the population background risk of malformations (37). There is no evidence in the literature linking paternal mycophenolate exposure with adverse neonatal effects (37). There have been no studies into spermatogenesis and male fertility, however an incidental review found that patients had normal spermiogram results (36). Additionally in animal studies on rats, fertility and offspring did not appear to be affected by doses four times higher than that found to cause malformations in the young of pregnant females (40). Product manufacturer recommends the use of barrier contraception during and for 13 weeks after the last dose.